Skip to Main Content

480

Views

3

CrossRef citations to date

0

Altmetric

Original Articles

Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Group

Maximiliano Ramia de Capa Harvard Medical School, Boston, MA, USA;b Beth Israel Deaconess Medical Center, Boston, MA, USA;c North Bristol NHS Trust, Bristol, UKCorrespondence[email protected]

https://orcid.org/0000-0002-7659-7013 View further author information

,

Leo P. Wua Harvard Medical School, Boston, MA, USA;b Beth Israel Deaconess Medical Center, Boston, MA, USAView further author information

,

Christian Hirta Harvard Medical School, Boston, MA, USA;b Beth Israel Deaconess Medical Center, Boston, MA, USAView further author information

,

German A. Pihana Harvard Medical School, Boston, MA, USA;b Beth Israel Deaconess Medical Center, Boston, MA, USAView further author information

,

Sanjay S. Pateld Weill Cornell Medical College, New York, NY, USAView further author information

,

Wayne Tamd Weill Cornell Medical College, New York, NY, USAView further author information

,

Carlos E. Bueso-Ramose The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information

,

Rashmi Kanagal-Shamannae The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information

,

Philipp W. Raessf Department of Pathology, Oregon Health & Science University, Portland, OR, USAView further author information

,

Alexa Siddong Yale School of Medicine, New Haven, CT, USAView further author information

,

Damodaran Narayanana Harvard Medical School, Boston, MA, USA;h Brigham and Women’s Hospital, Boston, MA, USAView further author information

,

Elizabeth A. Morgana Harvard Medical School, Boston, MA, USA;h Brigham and Women’s Hospital, Boston, MA, USAView further author information

,

Geraldine S. Pinkusa Harvard Medical School, Boston, MA, USA;h Brigham and Women’s Hospital, Boston, MA, USAView further author information

,

Emily F. Masoni Vanderbilt University Medical Center, Nashville, TN, USAView further author information

,

Eric D. Hsij Wake Forest Baptist Health, Winston-Salem, NC, USAView further author information

,

Heesun J. Rogersk Cleveland Clinic, Cleveland, OH, USAView further author information

,

Laura Tothl Department of Pathology, The University of New Mexico, Albuquerque, NM, USAView further author information

,

Kathryn Foucarl Department of Pathology, The University of New Mexico, Albuquerque, NM, USAView further author information

,

Stephanie N. Hurwitzm Department of Pathology, University of Pennsylvania, Philadelphia, PA, USAView further author information

,

Adam Baggm Department of Pathology, University of Pennsylvania, Philadelphia, PA, USAView further author information

,

Anton Retsn ARUP Laboratories, Salt Lake City, UT, USA;o Department of Pathology, University of Utah, Salt Lake City, UT, USAView further author information

,

Tracy I. Georgen ARUP Laboratories, Salt Lake City, UT, USA;o Department of Pathology, University of Utah, Salt Lake City, UT, USAView further author information

,

Attilio Orazip Texas Tech University Health Sciences Center, Lubbock, TX, USAView further author information

,

Daniel A. Arberq Department of Pathology, University of Chicago, Chicago, IL, USAView further author information

,

Robert P. Hasserjiana Harvard Medical School, Boston, MA, USA;r Massachusetts General Hospital, Boston, MA, USAView further author information

,

Olga K. Weinbergs UT Southwestern Medical Center, Dallas, TX, USACorrespondence[email protected]
View further author information

& for the Bone Marrow Pathology Group show all